GET DAILY SIGNALSDaVita (DVA) vs. Kimco Realty (KIM): Momentum Play or Steady Income Generator?
Key Takeaways
- DVA (DaVita) and KIM (Kimco Realty) operate in unrelated sectors, yet both posted earnings beats and raised full-year guidance in their most recent reporting periods, supporting constructive sentiment across each name.
- DVA has displayed stronger price momentum, with a sharp post-earnings surge and a year-to-date advance that has meaningfully outpaced the broader market, while KIM has delivered steadier, income-oriented performance.
- KIM offers a defensive, dividend-focused profile with record portfolio occupancy, whereas DVA carries higher operational and regulatory sensitivity tied to dialysis reimbursement and payer mix.
- Tickeron AI Verdict: DVA is the ticker of choice, favored for its stronger trend consistency, earnings catalysts, and relative momentum versus KIM.
- For deeper coverage of company-specific developments and intraday activity, explore DVA Major News, DVA Today's Price Move, KIM Major News, and KIM Today's Price Move.
- To see how automated strategies are navigating these and other names, explore Trending AI Robots.
Setting the Stage: A Growth-Income Comparison
Investors often face a classic choice between a high-growth healthcare provider and a steady real estate investment trust. The matchup between DVA and KIM highlights that tension. DVA, or DaVita, leads in kidney-care and dialysis services, while KIM, or Kimco Realty, focuses on grocery-anchored open-air shopping centers. Both companies recently delivered results that topped expectations and raised their full-year outlooks. Growth-oriented investors may lean toward DaVita’s momentum, whereas those seeking income might appreciate Kimco’s dividend and portfolio stability. This comparison looks at relative performance and positioning to help assess which approach fits the current market.
DaVita (DVA) Overview and Recent Results
DVA operates thousands of outpatient dialysis centers in the U.S. and abroad. In its latest quarter, the company reported adjusted EPS well above consensus estimates, with revenue up about 6% year over year thanks to solid treatment volumes and higher revenue per treatment. Management raised and tightened its full-year adjusted EPS and operating income guidance, pointing to better volume expectations and reduced patient-care costs. The stock reacted with a strong post-earnings move, and Deutsche Bank recently upgraded the shares to Buy with an increased price target. DaVita’s year-to-date performance has been solid, though it has eased from recent highs. Expansion of value-based care and its Integrated Kidney Care platform have helped sentiment, but reimbursement risks, payer-mix shifts, and competition stay important factors to monitor. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.
Kimco Realty (KIM) Overview and Recent Results
KIM is a REIT focused on neighborhood and community shopping centers, mostly grocery-anchored and located in suburban markets. Its most recent quarter showed funds from operations slightly ahead of consensus, with modest year-over-year revenue growth. The company reached record portfolio occupancy, accelerated same-property net operating income growth, and raised its full-year net income and FFO per share outlook. It also increased its quarterly dividend, reinforcing its income focus. Performance has been consistent rather than dramatic: shares are higher year to date but have lagged over the past three months. Key risks include e-commerce pressures, elevated debt, and interest-rate sensitivity around refinancing.
Head-to-Head Comparison
The main differences lie in business models and risk exposures. DVA is a growth-oriented healthcare operator reliant on treatment volumes, reimbursement rates, and value-based care expansion, which leaves it exposed to policy and payer-mix shifts. KIM is a capital-intensive REIT whose results depend on occupancy, rental spreads, and financing costs, making it more sensitive to interest rates and e-commerce trends. On momentum, DaVita has led with a stronger year-to-date gain and a clear earnings catalyst, while Kimco has provided steadier, dividend-supported returns. Kimco’s necessity-based retail focus and record occupancy give it a defensive edge that DaVita’s reimbursement concentration lacks. Valuation and income profiles also differ: Kimco offers a meaningful dividend yield, whereas DaVita emphasizes share repurchases and earnings growth. Market sentiment currently favors DaVita’s momentum, but Kimco appeals to investors prioritizing stability and income.
Tickeron AI Verdict
Based on trend consistency, relative momentum, and recent catalysts, Tickeron’s AI analysis points to DVA over KIM in the present environment. DaVita combines an earnings beat, raised guidance, an analyst upgrade, and stronger year-to-date trend characteristics that align with momentum signals. Kimco provides stability and income, yet its more modest price momentum and interest-rate sensitivity place it at a relative disadvantage in a trend-based view. This assessment reflects current positioning and could shift with new information.
Exploring Automated Trading Approaches
In my research process, I frequently review Tickeron’s Trending AI Robots to understand how automated systems are positioned across names like these. The page highlights a curated selection of bots suited to current conditions, allowing comparison of different strategies, risk levels, and performance records before deciding on any approach.
Disclaimer
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Contributor
Harry Richardson — Algorithmic Trader & Strategy Developer Harry is an algorithmic trader specializing in impulse and breakout trading strategies across cryptocurrency and equity markets. With more than 10 years of experience in developing automated trading systems, he focuses on building structured algorithms designed to capture momentum while maintaining strict risk control. His approach combines quantitative analysis, real-market execution, and continuous performance monitoring. Vitalii prioritizes risk management, drawdown control, and strategy stability over short-term optimization, ensuring algorithms are adaptable to changing market conditions. He has developed and tested hundreds of automated strategies, working extensively with live trading environments, forward testing, and portfolio-level algorithm management. His work centers on transforming trading ideas into fully operational, scalable automated systems.
DVA saw its Stochastic Oscillator recovers from the overbought zone
The Stochastic Oscillator for DVA moved out of overbought territory on October 20, 2026. This could be a bearish sign for the stock and investors may want to consider selling or taking a defensive position. A.I.dvisor looked at 66 similar instances where the indicator exited the overbought zone. In 44 of the 66 cases the stock moved lower. This puts the odds of a downward move at 67%.
Technical Analysis (Indicators)
Bearish Trend Analysis
Following a 3-day decline, the stock is projected to fall further. Considering past instances where DVA declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 55%.
DVA broke above its upper Bollinger Band on October 15, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Aroon Indicator for DVA entered a downward trend on October 22, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Bullish Trend Analysis
The Momentum Indicator moved above the 0 level on October 28, 2026. You may want to consider a long position or call options on DVA as a result. In 61 of 87 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 70%.
The Moving Average Convergence Divergence (MACD) for DVA just turned positive on October 05, 2026. Looking at past instances where DVA's MACD turned positive, the stock continued to rise in 28 of 41 cases over the following month. The odds of a continued upward trend are 68%.
DVA moved above its 50-day moving average on October 22, 2026 date and that indicates a change from a downward trend to an upward trend.
The 10-day moving average for DVA crossed bullishly above the 50-day moving average on October 15, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 10 of 13 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 77%.
Following a +6.13% 3-day Advance, the price is estimated to grow further. Considering data from situations where DVA advanced for three days, in 242 of 352 cases, the price rose further within the following month. The odds of a continued upward trend are 69%.
Fundamental Analysis (Ratings)
The Tickeron SMR rating for this company is 7 (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron PE Growth Rating for this company is 25 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 48 (best 1 - 100 worst), indicating steady price growth. DVA’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 48 (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 85, placing this stock slightly better than average.
The Tickeron Valuation Rating of 66 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (-15.338) is normal, around the industry mean (204.282). P/E Ratio (14.833) is within average values for comparable stocks, (19.375). Projected Growth (PEG Ratio) (0.436) is also within normal values, averaging (2.498). Dividend Yield (0.000) settles around the average of (0.096) among similar stocks. P/S Ratio (0.968) is also within normal values, averaging (2.688).
Notable companies
Industry description
Market Cap
High and low price notable news
Volume
Fundamental Analysis Ratings
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Advertisement
General Information
a provider of integrated dialysis services for patients suffering from chronic kidney failure
Industry HospitalNursingManagement
Advertisement